合成生物学市場：ツール、技術、用途別-2023-2030年の世界予測

合成生物学の世界市場は、2023年にCAGR 20.93%で138億8,000万米ドル、2030年には537億6,000万米ドルに達すると予測され、大きく成長すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の合成生物学市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.合成生物学の世界市場規模および予測は？

2.予測期間中、世界の合成生物学市場を形成するCOVID-19の阻害要因と影響は？

3.合成生物学の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.合成生物学の世界市場における競争戦略は？

5.合成生物学の世界市場における技術動向と規制の枠組みは？

6.合成生物学の世界市場における主要ベンダーの市場シェアは？

7.合成生物学の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 新薬やワクチンの開発での利用が増加
    • 合成生物学ベースのポイントオブケア診断デバイスの拡張
    • さまざまな産業用途で合成生物学の需要が加速
  • 抑制要因
    • 合成生物学テクノロジーの使用に伴うリスク
  • 機会
    • 遺伝子編集と次世代シークエンシングにおける技術の進歩
    • 合成生物学アプリケーションの拡張のための研究開発資金と投資の増加
  • 課題
    • 生体部品のモジュール化・標準化における合成生物学の制約
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 合成生物学市場ツール別

• DNAツール
• 一般的なツール
• 数学的モデリングとコンピュータ支援設計ツール
• プロテインツール
• RNAツール

第7章 合成生物学市場：技術別

• バイオインフォマティクス
• 細胞配列決定
• 細胞の合成と組み立て
• クローン作成
• マイクロ流体工学
• ナノテクノロジー
• オミクステクノロジーズ
• 部位特異的突然変異誘発

第8章 合成生物学市場：最終用途別

• 農業
• 化粧品とパーソナルケア
• エネルギーと天然資源
• 環境
  • バイオレメディエーション
  • バイオセンシング
• 飲食品
• ヘルスケアと医薬品
  • 人工組織と組織再生
  • 創薬と治療
• 紙と繊維

第9章 南北アメリカの合成生物学市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の合成生物学市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの合成生物学市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別
  • 合併・買収
  • 契約、コラボレーション、パートナーシップ
  • 新製品発売と機能強化
  • 投資、資金調達

第13章 掲載企業一覧

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. SYNTHETIC BIOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. SYNTHETIC BIOLOGY MARKET SIZE, 2022 VS 2030
• FIGURE 3. SYNTHETIC BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2022 VS 2030 (%)
• FIGURE 5. SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
• FIGURE 6. SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
• FIGURE 7. SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. SYNTHETIC BIOLOGY MARKET DYNAMICS
• FIGURE 9. SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. SYNTHETIC BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. SYNTHETIC BIOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. SYNTHETIC BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 5. SYNTHETIC BIOLOGY MARKET SIZE, BY DNA TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. SYNTHETIC BIOLOGY MARKET SIZE, BY GENERAL TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. SYNTHETIC BIOLOGY MARKET SIZE, BY MATHEMATICAL MODELLING & COMPUTER-AIDED DESIGN TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. SYNTHETIC BIOLOGY MARKET SIZE, BY RNA TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 11. SYNTHETIC BIOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. SYNTHETIC BIOLOGY MARKET SIZE, BY CELL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. SYNTHETIC BIOLOGY MARKET SIZE, BY CELL SYNTHESIS & ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. SYNTHETIC BIOLOGY MARKET SIZE, BY CLONING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. SYNTHETIC BIOLOGY MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. SYNTHETIC BIOLOGY MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. SYNTHETIC BIOLOGY MARKET SIZE, BY OMICS TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. SYNTHETIC BIOLOGY MARKET SIZE, BY SITE-DIRECTED MUTAGENESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 20. SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. SYNTHETIC BIOLOGY MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. SYNTHETIC BIOLOGY MARKET SIZE, BY ENERGY & NATURAL RESOURCES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 24. SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. SYNTHETIC BIOLOGY MARKET SIZE, BY BIOREMEDIATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. SYNTHETIC BIOLOGY MARKET SIZE, BY BIOSENSING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. SYNTHETIC BIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 29. SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. SYNTHETIC BIOLOGY MARKET SIZE, BY ARTIFICIAL TISSUE & TISSUE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. SYNTHETIC BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. SYNTHETIC BIOLOGY MARKET SIZE, BY PAPER & TEXTILE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 49. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 50. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 53. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 76. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 77. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 80. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 81. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 82. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 84. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 85. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 167. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 168. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 169. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 170. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 171. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 187. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 188. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 190. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 191. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 192. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 193. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 194. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 195. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 196. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 242. SYNTHETIC BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 243. SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 244. SYNTHETIC BIOLOGY MARKET LICENSE & PRICING

The Global Synthetic Biology Market is forecasted to grow significantly, with a projected USD 13.88 billion in 2023 at a CAGR of 20.93% and expected to reach a staggering USD 53.76 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Synthetic Biology Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Synthetic Biology Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Tools, market is studied across DNA Tools, General Tools, Mathematical Modelling & Computer-aided Design Tools, Protein Tools, and RNA Tools. The General Tools commanded largest market share of 26.76% in 2022, followed by Mathematical Modelling & Computer-aided Design Tools.

Based on Technology, market is studied across Bioinformatics, Cell Sequencing, Cell Synthesis & Assembly, Cloning, Microfluidics, Nanotechnology, Omics Technologies, and Site-directed Mutagenesis. The Cell Synthesis & Assembly commanded largest market share of 13.44% in 2022, followed by Cell Sequencing.

Based on End-Use, market is studied across Agriculture, Cosmetics & Personal Care, Energy & Natural Resources, Environment, Food & Beverage, Healthcare & Pharmaceuticals, and Paper & Textile. The Environment is further studied across Bioremediation and Biosensing. The Healthcare & Pharmaceuticals is further studied across Artificial Tissue & Tissue Regeneration and Drug Discovery & Therapeutics. The Healthcare & Pharmaceuticals commanded largest market share of 16.02% in 2022, followed by Food & Beverage.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 38.45% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Synthetic Biology Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Synthetic Biology Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Synthetic Biology Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Synthetic Biology Market?

4. What is the competitive strategic window for opportunities in the Global Synthetic Biology Market?

5. What are the technology trends and regulatory frameworks in the Global Synthetic Biology Market?

6. What is the market share of the leading vendors in the Global Synthetic Biology Market?

7. What modes and strategic moves are considered suitable for entering the Global Synthetic Biology Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Synthetic Biology Market, by Tools, 2022 vs 2030
• 4.3. Synthetic Biology Market, by Technology, 2022 vs 2030
• 4.4. Synthetic Biology Market, by End-Use, 2022 vs 2030
• 4.5. Synthetic Biology Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing use for novel drug and vaccines development
    • 5.1.1.2. Expansion of synthetic biology based point-of-care diagnostics devices
    • 5.1.1.3. Accelerating demand for synthetic biology in various industrial applications
  • 5.1.2. Restraints
    • 5.1.2.1. Risks associated with the use of synthetic biology technology
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in gene editing and next generation sequencing
    • 5.1.3.2. Rising R&D funding and investments for expansion of synthetic biology applications
  • 5.1.4. Challenges
    • 5.1.4.1. Constraints of synthetic biology in modularization and standardization of biological parts
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Synthetic Biology Market, by Tools

• 6.1. Introduction
• 6.2. DNA Tools
• 6.3. General Tools
• 6.4. Mathematical Modelling & Computer-aided Design Tools
• 6.5. Protein Tools
• 6.6. RNA Tools

7. Synthetic Biology Market, by Technology

• 7.1. Introduction
• 7.2. Bioinformatics
• 7.3. Cell Sequencing
• 7.4. Cell Synthesis & Assembly
• 7.5. Cloning
• 7.6. Microfluidics
• 7.7. Nanotechnology
• 7.8. Omics Technologies
• 7.9. Site-directed Mutagenesis

8. Synthetic Biology Market, by End-Use

• 8.1. Introduction
• 8.2. Agriculture
• 8.3. Cosmetics & Personal Care
• 8.4. Energy & Natural Resources
• 8.5. Environment
  • 8.5.1. Bioremediation
  • 8.5.2. Biosensing
• 8.6. Food & Beverage
• 8.7. Healthcare & Pharmaceuticals
  • 8.7.1. Artificial Tissue & Tissue Regeneration
  • 8.7.2. Drug Discovery & Therapeutics
• 8.8. Paper & Textile

9. Americas Synthetic Biology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Synthetic Biology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Synthetic Biology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player
  • 12.3.1. Merger & Acquisition
    • 12.3.1.1. Moderna, Becoming A Buyer, Acquires A Synthetic Biology Specialist.
    • 12.3.1.2. Ginkgo To Acquire Synbio Competitor Zymergen.
  • 12.3.2. Agreement, Collaboration, & Partnership
    • 12.3.2.1. Asimov Partners With IGEM To Support The Next Generation of Synthetic Biologists.
  • 12.3.3. New Product Launch & Enhancement
    • 12.3.3.1. NREL Launches Synthetic Biology Project To Advance Biofuel Discovery Technologies With LanzaTech, Northwestern, and Yale.
    • 12.3.3.2. Tierra Biosciences Launches 'proteins-On-Demand' Platform To Speed Up Synbio Engineering.
  • 12.3.4. Investment & Funding
    • 12.3.4.1. Synthetic Biology Startup D-Nome Raises USD 1.5 Million In Funding From Ankur Capital, Campus Fund.
    • 12.3.4.2. Northwestern and MIT Receive Funding From Army's Synthetic Biology Center.

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing